Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MELPHALAN FLUFENAMIDE: 89 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
89
Total FAERS Reports
19 (21.3%)
Deaths Reported
26
Hospitalizations
89
As Primary/Secondary Suspect
7
Life-Threatening

First Report: 20150701 · Latest Report: 20240725

What Are the Most Common MELPHALAN FLUFENAMIDE Side Effects?

#1 Most Reported
Platelet count decreased
11 reports (12.4%)
#2 Most Reported
Drug ineffective
10 reports (11.2%)
#3 Most Reported
Nausea
9 reports (10.1%)

All MELPHALAN FLUFENAMIDE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Platelet count decreased 11 12.4% 1 1
Drug ineffective 10 11.2% 1 6
Nausea 9 10.1% 1 0
Cytopenia 8 9.0% 2 3
Sepsis 8 9.0% 4 6
Thrombocytopenia 8 9.0% 1 1
Neutropenia 7 7.9% 1 0
White blood cell count decreased 7 7.9% 2 1
Anaemia 5 5.6% 1 1
Diarrhoea 5 5.6% 2 0
Disease progression 5 5.6% 1 0
Fatigue 5 5.6% 1 1
Off label use 5 5.6% 1 1

Who Reports MELPHALAN FLUFENAMIDE Side Effects? Age & Gender Data

Gender: 46.2% female, 53.8% male. Average age: 66.9 years. Most reports from: US. View detailed demographics →

Is MELPHALAN FLUFENAMIDE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2015 1 0 0
2019 2 1 1
2020 3 0 2
2021 34 8 11
2022 1 1 1
2023 2 0 2
2024 2 0 0

View full timeline →

What Is MELPHALAN FLUFENAMIDE Used For?

IndicationReports
Plasma cell myeloma 57
Product used for unknown indication 22
Plasma cell myeloma refractory 7

Official FDA Label for MELPHALAN FLUFENAMIDE

Official prescribing information from the FDA-approved drug label.